Prashin Karanam
About Prashin Karanam
Prashin Karanam is the Imaging Operations Lead at Bristol-Myers Squibb, with extensive experience in oncology and clinical project management within the pharmaceuticals industry.
Current Role at Bristol-Myers Squibb
Prashin Karanam currently serves as the Imaging Operations Lead at Bristol-Myers Squibb, a role he has been in since July 2019. In this capacity, he oversees all imaging operations, coordinating critical aspects of medical imaging within clinical trials for oncology treatments. His work ensures the consistent and accurate use of imaging protocols to track patient responses to cancer therapies, reflecting his expertise in RECIST (Response Evaluation Criteria in Solid Tumors).
Previous Experience at Novartis
Prashin Karanam worked at Novartis as the Senior Imaging Operations Manager in East Hanover, New Jersey, from 2018 to 2019. During this period, he was responsible for managing advanced imaging protocols and ensuring accurate data collection in clinical trials. His role demanded in-depth knowledge of imaging techniques and rigorous attention to detail to support the efficacy and safety assessments of new pharmaceutical products.
Clinical Site and Project Management Roles
Prashin Karanam has held several pivotal roles in clinical site and project management. Before rejoining Bristol-Myers Squibb, he was a Clinical Site Manager there for 4 months in 2018, based in Lawrenceville, New Jersey. Prior to this, at Bioclinica, he progressed through several positions including Clinical Project Manager (2016-2018), Assistant Clinical Project Manager (2015-2016), and Project Support Specialist (2013-2015). These roles involved managing the logistical and operational aspects of clinical trials, showcasing his ability to handle complex project management tasks within the pharmaceutical industry.
Educational Background in Biological Sciences
Prashin Karanam earned his Bachelor's Degree in Biology/Biological Sciences, General from Rutgers University-New Brunswick, completing his studies over the course of six years from 2006 to 2012. This academic foundation provided him with a broad understanding of biological systems, crucial for his subsequent roles in managing clinical and imaging projects within the pharmaceuticals industry.
Expertise in RECIST and Oncology Imaging
Prashin Karanam possesses specialized expertise in RECIST (Response Evaluation Criteria in Solid Tumors), a set of published guidelines essential for evaluating the responses of cancer patients to treatments. His extensive experience in oncology, particularly in the context of medical imaging, allows him to contribute significantly to the precise tracking of treatment outcomes. His technical proficiency ensures that imaging data is consistently accurate and reliable, which is vital for the development and approval of new cancer therapies.